Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Recruiting · NCT06066333 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma | Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, adrenal cortex carcinoma, adrenal cortex disorder, adrenal cortex neoplasm, adrenal gland cancer, adrenal gland disorder, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm | Recruiting | Phase 2 | 2026-04-15 | NCT06066333 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | Basking Ridge | United States | 56 |
| Memorial Sloan Kettering Bergen (All Protocol Activities) | Montvale | United States | 82 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | United States | 92 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Uniondale | United States | 53 |
| Memorial Sloan Kettering Suffolk-Commack | Commack | United States | 2 |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | United States | 86 |